DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Hyatt Regency Bethesda

2025 年 02 月 24 日 7:00 上午 - 2025 年 02 月 25 日 4:20 下午

One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814-5326

Advertising and Promotion Regulatory Affairs Conference

Explore the current state of compliance for marketing both biopharmaceuticals and medical devices.

Early Bird Registration Expires

DAYS

HOURS

MINUTES

SECONDS

Session 6: Unlocking the Potential of your Promotional Review Committee OR Navigating the Complexities of PRC Management

Session Chair(s)

Micheline  Awad, MBA

Micheline Awad, MBA

Sr. Director, Regulatory Advertising, Promotion, and Labeling

Day One Biopharmaceuticals, United States

Georgina  Lee, PharmD

Georgina Lee, PharmD

Executive Director, Regulatory Advertising and Promotion

Sage Therapeutics, United States

This session will delve into the strategic management of promotional review committees (PRC). We will explore the best practices for ensuring launch readiness, managing post-approval activities, reviewing and approving CFL data, and making informed risk decisions. Additionally, we will discuss effective training strategies, from training project owners on regulatory fundamentals to preparing new regulatory reviewers. At the end of this session, attendees will gain valuable insights to optimize their PRC and drive maximum promotional success.

Learning Objective :
  • Identify strategies to streamline the PRC review and approval process for product launches, post-approval activities, CFL data and determining the appropriateness of supporting studies
  • Develop effective training programs to equip project owners and regulatory reviewers with the necessary knowledge and skills to ensure compliance and mitigate risks
  • Explore frameworks and tools for conducting risk assessment and making informed decisions about the use of CFL data

Speaker(s)

Representative Invited

Speaker

Representative Invited

Sage Therapeutics, United States

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。